Genpact price target raised to $55 from $53 at TD Cowen

TD Cowen raised the firm’s price target on Genpact (G) to $55 from $53 and keeps a Buy rating on the shares. The firm said its investor day produced, a healthy yet prudent med-term outlook that reflects higher revenue and EPS growth versus FY26E Street, favorable net impacts on GenAI/agentic adoption and a proactive strategy that disrupts its core business paired with an active roadmap. At discounted valuation, Cowen thinks it’s the catalyst to restart momentum in the shares.